Thrombus Treatment Market Research Report Information by Type (Atrial Thrombus [Right Atrial Thrombus and Left Atrial Thrombus] and Venous Thrombus), by Treatment (Medical Therapy [Antiplatelets, Anticoagulants, and Thrombolytics], Surgery, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) - Forecast till 2032

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

1.1 OVERVIEW

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING INCIDENCE OF TRAUMA CASES

4.2.2 RISING ADOPTION OF SEDENTARY LIFESTYLE

4.3 RESTRAINTS

4.3.1 RISKS ASSOCIATED WITH THROMBOSIS DRUGS

4.4 OPPORTUNITIES

4.4.1 NEW PRODUCT APPROVALS AND LAUNCHES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL THROMBUS TREATMENT MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON PRODUCTION

5.3.3 DEMAND-SUPPLY GAP ANALYSIS

5.3.4 IMPACT ON PRICING

5.4 NUMBER OF PROCEDURES FOR PULMONARY EMBOLISM

6 GLOBAL THROMBUS TREATMENT MARKET, BY TYPE

6.1 OVERVIEW

6.2 ATRIAL THROMBUS

6.3 VENOUS THROMBUS

7 GLOBAL THROMBUS TREATMENT MARKET, BY TREATMENT

7.1 OVERVIEW

7.2 MEDICAL THERAPY

7.3 SURGERY

7.4 OTHERS

8 GLOBAL THROMBUS TREATMENT MARKET, BY REGION

8.1 OVERVIEW

8.1.1 NORTH AMERICA

8.1.1.1 US

8.1.1.2 CANADA

8.1.2 EUROPE

8.1.2.1 GERMANY

8.1.2.2 UK

8.1.2.3 FRANCE

8.1.2.4 ITALY

8.1.2.5 SPAIN

8.1.2.6 REST OF EUROPE

8.1.3 ASIA-PACIFIC

8.1.3.1 JAPAN

8.1.3.2 CHINA

8.1.3.3 INDIA

8.1.3.4 AUSTRALIA

8.1.3.5 SOUTH KOREA

8.1.3.6 REST OF ASIA-PACIFIC

8.1.4 REST OF THE WORLD

8.1.4.1 MIDDLE EAST

8.1.4.2 AFRICA

8.1.4.3 LATIN AMERICA

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW

9.2 COMPETITIVE BENCHMARKING

9.3 MAJOR GROWTH STRATEGY IN THE GLOBAL THROMBUS TREATMENT MARKET

9.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL THROMBUS TREATMENT MARKET

9.5 KEY DEVELOPMENT ANALYSIS

9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

9.6.1 PRODUCT APPROVALS/PRODUCT LAUNCHES

9.6.2 PARTNERSHIP/COLLABORATION

9.7 MAJOR PLAYERS FINANCIAL MATRIX

9.7.1 SALES (USD MILLION), 2021

9.7.2 R&D (USD MILLION), 2021

10 COMPANY PROFILES

10.1 TEVA PHARMACEUTICAL INDUSTRIES LTD.

10.1.1 COMPANY OVERVIEW

10.1.2 FINANCIAL ANALYSIS

10.1.3 PRODUCTS OFFERED

10.1.4 KEY DEVELOPMENTS

10.1.5 SWOT ANALYSIS

10.1.6 KEY STRATEGIES

10.2 SANOFI

10.2.1 COMPANY OVERVIEW

10.2.2 FINANCIAL OVERVIEW

10.2.3 PRODUCTS OFFERED

10.2.4 KEY DEVELOPMENTS

10.2.5 SWOT ANALYSIS

10.2.6 KEY STRATEGIES

10.3 PFIZER INC.

10.3.1 COMPANY OVERVIEW

10.3.2 FINANCIAL OVERVIEW

10.3.3 PRODUCTS OFFERED

10.3.4 KEY DEVELOPMENTS

10.3.5 SWOT ANALYSIS

10.3.6 KEY STRATEGIES

10.4 BAYER AG

10.4.1 COMPANY OVERVIEW

10.4.2 FINANCIAL OVERVIEW

10.4.3 PRODUCTS OFFERED

10.4.4 KEY DEVELOPMENTS

10.4.5 KEY STRATEGIES

10.5 ANGIODYNAMICS.

10.5.1 COMPANY OVERVIEW

10.5.2 FINANCIAL OVERVIEW

10.5.3 PRODUCTS OFFERED

10.5.4 KEY DEVELOPMENTS

10.5.5 KEY STRATEGIES

10.6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH

10.6.1 COMPANY OVERVIEW

10.6.2 FINANCIAL OVERVIEW

10.6.3 PRODUCTS OFFERED

10.6.4 KEY DEVELOPMENTS

10.6.5 SWOT ANALYSIS

10.6.6 KEY STRATEGIES

10.7 BRISTOL-MYERS SQUIBB COMPANY

10.7.1 COMPANY OVERVIEW

10.7.2 FINANCIAL OVERVIEW

10.7.3 PRODUCTS OFFERED

10.7.4 KEY DEVELOPMENTS

10.7.5 KEY STRATEGIES

10.8 ASPEN HOLDINGS

10.8.1 COMPANY OVERVIEW

10.8.2 FINANCIAL OVERVIEW

10.8.3 PRODUCTS OFFERED

10.8.4 KEY DEVELOPMENTS

10.8.5 KEY STRATEGIES

10.9 JOHNSON & JOHNSON SERVICES, INC.

10.9.1 COMPANY OVERVIEW

10.9.2 FINANCIAL OVERVIEW

10.9.3 PRODUCTS OFFERED

10.9.4 KEY DEVELOPMENTS

10.9.5 SWOT ANALYSIS

10.9.6 KEY STRATEGIES

10.10 DAIICHI SANKYO COMPANY, LIMITED

10.10.1 COMPANY OVERVIEW

10.10.2 FINANCIAL OVERVIEW

10.10.3 PRODUCTS OFFERED

10.10.4 KEY DEVELOPMENTS

10.10.5 KEY STRATEGIES

11 APPENDIX

11.1 REFERENCES

11.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 NUMBER OF PROCEDURES FOR PULMONARY EMBOLISM, BY REGION (2021)

TABLE 4 GLOBAL THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 5 GLOBAL THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY REGION, 2018–2030 (USD MILLION)

TABLE 6 GLOBAL THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)

TABLE 7 GLOBAL THROMBUS TREATMENT MARKET, FOR RIGHT ATRIAL THROMBUS, BY REGION, 2018–2030 (USD MILLION)

TABLE 8 GLOBAL THROMBUS TREATMENT MARKET, FOR LEFT ATRIAL THROMBUS, BY REGION, 2018–2030 (USD MILLION)

TABLE 9 GLOBAL THROMBUS TREATMENT MARKET, FOR VENOUS THROMBUS, BY REGION, 2018–2030 (USD MILLION)

TABLE 10 GLOBAL THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 11 GLOBAL THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY REGION, 2018–2030 (USD MILLION)

TABLE 12 GLOBAL THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TYPE, 2018–2030 (USD MILLION)

TABLE 13 GLOBAL THROMBUS TREATMENT MARKET, FOR ANTIPLATELETS BY TYPE, 2018–2030 (USD MILLION)

TABLE 14 GLOBAL THROMBUS TREATMENT MARKET, FOR ANTICOAGULANTS BY TYPE, 2018–2030 (USD MILLION)

TABLE 15 GLOBAL THROMBUS TREATMENT MARKET, FOR THROMBOLYTICS BY TYPE, 2018–2030 (USD MILLION)

TABLE 16 GLOBAL THROMBUS TREATMENT MARKET, FOR SURGERY, BY REGION, 2018–2030 (USD MILLION)

TABLE 17 GLOBAL THROMBUS TREATMENT MARKET, FOR OTHERS, BY REGION, 2018–2030 (USD MILLION)

TABLE 18 GLOBAL: THROMBUS TREATMENT MARKET, BY REGION, 2018–2030 (USD MILLION)

TABLE 19 NORTH AMERICA: THROMBUS TREATMENT MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 20 NORTH AMERICA: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 21 NORTH AMERICA: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030

TABLE 22 NORTH AMERICA: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 23 NORTH AMERICA: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 24 US: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 25 US: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)

TABLE 26 US: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018-2030

TABLE 27 US: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 28 CANADA: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 29 CANADA: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030

TABLE 30 CANADA: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 31 CANADA: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 32 EUROPE: THROMBUS TREATMENT MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 33 EUROPE: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 34 EUROPE: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)

TABLE 35 EUROPE: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 36 EUROPE: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TYPE, 2018–2030 (USD MILLION)

TABLE 37 GERMANY: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 38 GERMANY: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)

TABLE 39 GERMANY: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 40 GERMANY: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TYPE, 2018–2030 (USD MILLION)

TABLE 41 UK: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 42 UK: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)

TABLE 43 UK: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 44 UK: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TYPE, 2018–2030 (USD MILLION)

TABLE 45 FRANCE: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 46 FRANCE: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)

TABLE 47 FRANCE: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 48 FRANCE: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TYPE, 2018–2030 (USD MILLION)

TABLE 49 ITALY: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 50 ITALY: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)

TABLE 51 ITALY: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 52 ITALY: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TYPE, 2018–2030 (USD MILLION)

TABLE 53 SPAIN: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 54 SPAIN: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)

TABLE 55 SPAIN: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 56 SPAIN: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TYPE, 2018–2030 (USD MILLION)

TABLE 57 REST OF EUROPE: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 58 REST OF EUROPE: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018–2030 (USD MILLION)

TABLE 59 REST OF EUROPE: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 60 REST OF EUROPE: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TYPE, 2018–2030 (USD MILLION)

TABLE 61 ASIA-PACIFIC: THROMBUS TREATMENT MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 62 ASIA-PACIFIC: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 63 ASIA-PACIFIC: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030

TABLE 64 ASIA-PACIFIC: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 65 ASIA-PACIFIC: THROMBUS TREATMENT MARKET FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 66 JAPAN: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 67 JAPAN: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 68 JAPAN: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 69 JAPAN: THROMBUS TREATMENT MARKET FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 70 CHINA: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 71 CHINA: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 72 CHINA: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 73 CHINA: THROMBUS TREATMENT MARKET FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 74 INDIA: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 75 INDIA: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 76 INDIA: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 77 INDIA: THROMBUS TREATMENT MARKET FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 78 AUSTRALIA: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 79 AUSTRALIA: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 80 AUSTRALIA: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 81 AUSTRALIA: THROMBUS TREATMENT MARKET FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 82 SOUTH KOREA: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 83 SOUTH KOREA: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 84 SOUTH KOREA: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 85 SOUTH KOREA: THROMBUS TREATMENT MARKET FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 86 REST OF ASIA-PACIFIC: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 87 REST OF ASIA-PACIFIC: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030 (USD MILLION)

TABLE 88 REST OF ASIA-PACIFIC: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 89 REST OF ASIA-PACIFIC: THROMBUS TREATMENT MARKET FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 90 REST OF THE WORLD: THROMBUS TREATMENT MARKET, BY COUNTRY, 2018–2030 (USD MILLION)

TABLE 91 REST OF THE WORLD: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 92 REST OF THE WORLD: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030

TABLE 93 REST OF THE WORLD: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 94 REST OF THE WORLD: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 95 MIDDLE EAST: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 96 MIDDLE EAST: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030

TABLE 97 MIDDLE EAST: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 98 MIDDLE EAST: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 99 AFRICA: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 100 AFRICA: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030

TABLE 101 AFRICA: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 102 AFRICA: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 103 LATIN AMERICA: THROMBUS TREATMENT MARKET, BY TYPE, 2018–2030 (USD MILLION)

TABLE 104 LATIN AMERICA: THROMBUS TREATMENT MARKET, FOR ATRIAL THROMBUS, BY TYPE, 2018-2030

TABLE 105 LATIN AMERICA: THROMBUS TREATMENT MARKET, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 106 LATIN AMERICA: THROMBUS TREATMENT MARKET, FOR MEDICAL THERAPY, BY TREATMENT, 2018–2030 (USD MILLION)

TABLE 107 MAJOR PLAYERS IN THE GLOBAL THROMBUS TREATMENT MARKET

TABLE 108 MOST ACTIVE PLAYERS IN THE GLOBAL THROMBUS TREATMENT MARKET

TABLE 109 PRODUCT APPROVALS/PRODUCT LAUNCHES

TABLE 110 PARTNERSHIP/COLLABORATION

TABLE 111 TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCTS OFFERED

TABLE 112 TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY DEVELOPMENTS

TABLE 113 SANOFI: PRODUCTS OFFERED

TABLE 114 PFIZER INC.: PRODUCTS OFFERED

TABLE 115 BAYER AG: PRODUCTS OFFERED

TABLE 116 BAYER AG: KEY DEVELOPMENTS

TABLE 117 ANGIODYNAMICS.: PRODUCTS OFFERED

TABLE 118 ANGIODYNAMICS.: KEY DEVELOPMENTS

TABLE 119 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED

TABLE 120 BRISTOL-MYERS SQUIBB COMPANY: PRODUCTS OFFERED

TABLE 121 BRISTOL-MYERS SQUIBB COMPANY: KEY DEVELOPMENTS

TABLE 122 ASPEN HOLDINGS: PRODUCTS OFFERED

TABLE 123 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED

TABLE 124 JOHNSON & JOHNSON SERVICES INC.: KEY DEVELOPMENTS

TABLE 125 DAIICHI SANKYO COMPANY, LIMITED: PRODUCTS OFFERED

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 GLOBAL THROMBUS TREATMENT MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: GLOBAL THROMBUS TREATMENT MARKET

FIGURE 5 DRIVERS: IMPACT ANALYSIS

FIGURE 6 RESTRAINT: IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL THROMBUS TREATMENT MARKET

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL THROMBUS TREATMENT MARKET

FIGURE 9 GLOBAL THROMBUS TREATMENT MARKET, BY TYPE, 2021 & 2030 (USD MILLION)

FIGURE 10 GLOBAL THROMBUS TREATMENT MARKET SHARE (%), BY TYPE, 2021

FIGURE 11 GLOBAL THROMBUS TREATMENT MARKET, BY TREATMENT, 2021 & 2030 (USD MILLION)

FIGURE 12 GLOBAL THROMBUS TREATMENT MARKET SHARE (%), BY TREATMENT, 2021

FIGURE 13 GLOBAL: THROMBUS TREATMENT MARKET, BY REGION 2021 & 2030 (USD MILLION)

FIGURE 14 GLOBAL: THROMBUS TREATMENT MARKET SHARE (%), BY REGION 2021

FIGURE 15 NORTH AMERICA: THROMBUS TREATMENT MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 16 NORTH AMERICA: THROMBUS TREATMENT MARKET SHARE, BY COUNTRY, 2021

FIGURE 17 EUROPE: THROMBUS TREATMENT MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 18 ASIA-PACIFIC: THROMBUS TREATMENT MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 19 ASIA-PACIFIC: THROMBUS TREATMENT MARKET SHARE, BY COUNTRY, 2021

FIGURE 20 REST OF THE WORLD: THROMBUS TREATMENT MARKET SHARE (%), BY COUNTRY, 2021

FIGURE 21 REST OF THE WORLD: THROMBUS TREATMENT MARKET SHARE, BY COUNTRY, 2021

FIGURE 22 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 23 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL THROMBUS TREATMENT MARKET

FIGURE 24 GLOBAL THROMBUS TREATMENT MARKET: COMPETITIVE LANDSCAPE

FIGURE 25 SALES, 2021

FIGURE 26 R&D, 2021

FIGURE 27 TEVA PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 TEVA PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS

FIGURE 29 SANOFI: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 SANOFI.: SWOT ANALYSIS

FIGURE 31 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 PFIZER INC: SWOT ANALYSIS

FIGURE 33 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 34 ANGIODYNAMICS.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 35 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 36 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: SWOT ANALYSIS

FIGURE 37 BRISTOL-MYERS SQUIBB COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 38 ASPEN HOLDINGS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 39 JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW

FIGURE 40 JOHNSON & JOHNSON SERVICES, INC.: SWOT ANALYSIS

FIGURE 41 DAIICHI SANKYO COMPANY, LIMITED: FINANCIAL OVERVIEW